WEC
55
2
MA
57
2
WHR
64
3
XRX
41
6
EXR
60
3
JNJ
44
3
AVB
64
4
UPS
51
10
TXT
52
4
OI
42
5
PAYX
51
4
DLTR
38
4
DHR
38
3
WU
30
6
CMS
60
2
EOG
56
-2
FLR
55
6
EW
39
2
COF
58
3
AMAT
42
6
WEC
55
2
MA
57
2
WHR
64
3
XRX
41
6
EXR
60
3
JNJ
44
3
AVB
64
4
UPS
51
10
TXT
52
4
OI
42
5
PAYX
51
4
DLTR
38
4
DHR
38
3
WU
30
6
CMS
60
2
EOG
56
-2
FLR
55
6
EW
39
2
COF
58
3
AMAT
42
6
Financhill
Back

Genfit SA Vs. Akari Therapeutics PLC Industry Stock Comparison

Sell
18

GNFT
Genfit SA

Last Price:
4.21
Seasonality Move:
12.91%
Sell
10

AKTX
Akari Therapeutics PLC

Last Price:
1.25
Seasonality Move:
-8.33%
Sell
18
Genfit SA (GNFT) is a Sell

Is Genfit SA a Buy, Sell or Hold?

  • The current Genfit SA [GNFT] share price is $4.24. The Score for GNFT is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
  • GNFT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
10
Akari Therapeutics PLC (AKTX) is a Sell

Is Akari Therapeutics PLC a Buy, Sell or Hold?

  • The current Akari Therapeutics PLC [AKTX] share price is $1.24. The Score for AKTX is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
  • AKTX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

GNFT Stock Price Chart

What is Genfit SA's stock price today?

  • The Genfit SA share price today is $4.24
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GNFT is experiencing slight buying pressure.

AKTX Stock Price Chart

What is Akari Therapeutics PLC's stock price today?

  • The Akari Therapeutics PLC share price today is $1.24
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKTX is experiencing slight selling pressure.

GNFT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.32 Sell
Relative Strength Index (14 RSI): 26.48 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.74 - 5.92) Sell
Bollinger Bands (100): (4.05 - 5.45) Sell

AKTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 24.41 Sell
Chaikin Money Flow: -35482 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.9 - 2.56) Sell
Bollinger Bands (100): (2.47 - 3.73) Sell

GNFT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.58 Sell
20-day SMA: 5.2 Sell
50-day SMA: 5.27 Sell
200-day SMA: 4.32 Sell
8-day EMA: 4.57 Sell
20-day EMA: 4.99 Sell
50-day EMA: 5.09 Sell
200-day EMA: 4.51 Sell

AKTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.93 Sell
20-day SMA: 2.23 Sell
50-day SMA: 2.61 Sell
200-day SMA: 2.54 Sell
8-day EMA: 1.81 Sell
20-day EMA: 2.13 Sell
50-day EMA: 2.52 Sell
200-day EMA: 2.93 Sell

Genfit SA Earnings Growth & GNFT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.85 per share, and a decrease next year of $1.47 per share.

Akari Therapeutics PLC Earnings Growth & AKTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and a decrease next year of $0.00 per share.

Genfit SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Akari Therapeutics PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):